This triple approach enhanced T cell infiltration, increased tumor antigen and major histocompatibility complex (MHC) expression, and maintained T cell effector functions in vivo, despite concerns that MEK inhibition might impair immune responses. Here, MAP2K7 is linked to neoplasm.